RETRACTABLE TECHNOLOGIES INC
RVPNYSE
$0.68
↓ -0.9%Jul 17 close · end-of-day
Price
1Y↑ +1.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$20.5M
Enterprise Value
$17.7M
P/E
—
P/S
0.6
P/B
0.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$37.1M
Net Income (TTM)
-$6.3M
Free Cash Flow (TTM)
—
Gross Margin
-2.1%
Operating Margin
-61.0%
Net Margin
-16.9%
ROE
-9.0%
ROIC
-26.6%
Debt / Equity
—
Net Cash
$2.8M
Return 1Y
+2.1%
Company profile
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products. The company distributes its products through general line and specialty distributors, as well as through international distributors.
- CEO
- Thomas J. Shaw
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 240
- Headquarters
- Texas
- Website
- retractable.com
Earnings
RVP Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$7.2M↓ -13.5%
Diluted EPS-$0.14↓ -60.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $81.9M | $188.4M | $94.8M | $43.6M | $33.0M | $38.3M |
| Gross profit | $37.0M | $95.4M | $28.3M | $9.1M | -$1.0M | $47,046.00 |
| Operating income | $24.1M | $72.6M | -$852,976.00 | -$11.5M | -$21.1M | -$21.2M |
| Net income | $24.2M | $56.1M | $5.1M | -$7.0M | -$11.9M | -$12.6M |
| Diluted EPS | $0.80 | $1.63 | $0.15 | -$0.24 | -$0.40 | -$0.43 |
| Operating cash flow | $19.0M | $32.8M | $16.8M | $2.8M | -$11.6M | -$7.1M |
| Free cash flow | -$2.1M | -$25.6M | -$61,949.00 | $1.9M | -$13.0M | — |
| Gross margin | 45.2% | 50.6% | 29.8% | 20.9% | -3.1% | 0.1% |
| Operating margin | 29.4% | 38.5% | -0.9% | -26.4% | -63.9% | -55.3% |
| Net margin | 29.6% | 29.8% | 5.4% | -16.1% | -36.0% | -32.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0M | $10.3M | $9.1M | $8.3M | $10.4M | $10.1M | $9.4M | $7.2M |
| Gross profit | -$419,924.00 | -$14,810.00 | -$2.5M | -$1,911.00 | -$107,090.00 | $1.7M | -$1.5M | -$838,408.00 |
| Operating income | -$5.8M | -$5.1M | -$7.2M | -$4.7M | -$5.1M | -$3.7M | -$7.7M | -$6.2M |
| Net income | -$14.2M | -$1.9M | $3.8M | -$10.5M | -$87,471.00 | $371,047.00 | -$2.3M | -$4.2M |
| Diluted EPS | -$0.48 | -$0.07 | $0.14 | -$0.35 | $0.00 | $0.01 | -$0.09 | -$0.14 |
| Operating cash flow | -$2.7M | -$5.7M | -$1.1M | -$1.5M | -$3.7M | -$1.3M | -$596,542.00 | -$1.4M |
| Free cash flow | -$2.8M | -$6.5M | -$1.4M | -$1.6M | -$4.1M | -$1.3M | — | -$1.4M |
| Gross margin | -7.0% | -0.1% | -27.5% | -0.0% | -1.0% | 16.7% | -16.2% | -11.7% |
| Operating margin | -95.6% | -49.6% | -79.6% | -56.4% | -49.1% | -36.2% | -81.7% | -85.9% |
| Net margin | -234.9% | -18.6% | 41.6% | -126.6% | -0.8% | 3.7% | -24.9% | -58.9% |
Company news
May 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-11-14 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 5,731 | $0.77 | $4,424.33 | filing |
| 2025-11-11 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 100 | $0.81 | $81.11 | filing |
| 2025-11-05 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 7,500 | $0.83 | $6,195.00 | filing |
| 2025-10-30 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 15,000 | $0.86 | $12,915.00 | filing |
| 2025-10-28 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 35,000 | $0.92 | $32,028.50 | filing |
| 2025-10-27 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 34,506 | $0.94 | $32,521.91 | filing |
| 2025-10-23 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 356 | $0.95 | $338.56 | filing |
| 2025-10-22 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 10,000 | $0.96 | $9,600.00 | filing |
| 2025-10-14 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 14,204 | $0.93 | $13,147.22 | filing |
| 2025-10-08 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 30,000 | $0.92 | $27,699.00 | filing |
| 2025-09-29 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 5,000 | $0.82 | $4,100.50 | filing |
| 2025-09-24 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 17,500 | $0.80 | $14,035.00 | filing |
| 2025-09-23 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 2,500 | $0.82 | $2,037.50 | filing |
| 2025-09-03 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 3,000 | $0.78 | $2,346.00 | filing |
| 2025-09-02 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 5,500 | $0.80 | $4,416.50 | filing |
| 2025-08-19 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 9,042 | $0.80 | $7,200.14 | filing |
| 2025-08-18 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 32,935 | $0.80 | $26,183.33 | filing |
| 2025-08-15 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 10,980 | $0.79 | $8,726.90 | filing |
| 2025-08-14 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 3,103 | $0.79 | $2,443.61 | filing |
| 2025-08-13 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 3,983 | $0.80 | $3,192.37 | filing |
| 2025-08-12 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 8,411 | $0.82 | $6,922.25 | filing |
| 2025-08-11 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 2,100 | $0.81 | $1,704.78 | filing |
| 2025-08-07 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 49,541 | $0.75 | $37,007.13 | filing |
| 2025-08-04 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 30,881 | $0.72 | $22,101.53 | filing |
| 2025-08-01 | SHAW THOMAS J· PRESIDENT AND CEO | Buy | 1,575 | $0.70 | $1,107.23 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.